$2.59 Billion is the total value of Artal Group S.A.'s 99 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 68.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $115,170,000 | +104.6% | 1,000,000 | +42.9% | 4.45% | +97.1% |
| MS | Buy | MORGAN STANLEYcall | $102,240,000 | +59.7% | 2,000,000 | +33.3% | 3.95% | +53.9% |
| BNTX | New | BIONTECH SEsponsored ads | $89,041,000 | – | 2,628,130 | +100.0% | 3.44% | – |
| ARGX | Buy | ARGENX SEsponsored adr | $56,182,000 | +146.5% | 350,000 | +75.0% | 2.17% | +137.5% |
| EPZM | Buy | EPIZYME INC | $55,350,000 | +257.7% | 2,250,000 | +50.0% | 2.14% | +244.8% |
| Z | Buy | ZILLOW GROUP INCcl c cap stk | $34,455,000 | +77.8% | 750,000 | +15.4% | 1.33% | +71.3% |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $33,557,000 | +59.8% | 2,546,040 | +8.5% | 1.30% | +53.9% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $29,220,000 | +45.7% | 3,000,000 | +20.0% | 1.13% | +40.4% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $28,823,000 | +36.1% | 1,750,000 | +16.7% | 1.11% | +31.2% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $28,650,000 | +121.1% | 600,000 | +50.0% | 1.11% | +112.9% |
| PYPL | New | PAYPAL HLDGS INC | $21,634,000 | – | 200,000 | +100.0% | 0.84% | – |
| XNCR | Buy | XENCOR INC | $18,915,000 | +86.9% | 550,000 | +83.3% | 0.73% | +80.0% |
| ARAV | Buy | ARAVIVE INC | $18,455,000 | +515.2% | 1,350,000 | +237.5% | 0.71% | +494.2% |
| FGEN | Buy | FIBROGEN INC | $17,156,000 | +157.8% | 400,000 | +122.2% | 0.66% | +148.3% |
| STNE | Buy | STONECO LTD | $15,956,000 | +52.9% | 400,000 | +33.3% | 0.62% | +47.4% |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $13,472,000 | +101.4% | 350,000 | +13.4% | 0.52% | +94.0% |
| HARP | New | HARPOON THERAPEUTICS INC | $12,572,000 | – | 850,000 | +100.0% | 0.49% | – |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $10,425,000 | +430.5% | 1,000,000 | +100.0% | 0.40% | +410.1% |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $10,222,000 | – | 50,000 | +100.0% | 0.40% | – |
| AXDX | Buy | ACCELERATE DIAGNOSTICS INC | $10,140,000 | +9.2% | 600,000 | +20.0% | 0.39% | +5.4% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INCcall | $8,455,000 | – | 100,000 | +100.0% | 0.33% | – |
| SELB | Buy | SELECTA BIOSCIENCES INC | $8,124,000 | +121.1% | 3,413,629 | +62.6% | 0.31% | +113.6% |
| BPMC | New | BLUEPRINT MEDICINES CORPcall | $8,011,000 | – | 100,000 | +100.0% | 0.31% | – |
| SLDB | Buy | SOLID BIOSCIENCES INC | $8,010,000 | -54.4% | 1,800,000 | +5.9% | 0.31% | -56.2% |
| CLVS | New | CLOVIS ONCOLOGY INCcall | $7,819,000 | – | 750,000 | +100.0% | 0.30% | – |
| IMUX | New | IMMUNIC INC | $6,111,000 | – | 630,019 | +100.0% | 0.24% | – |
| KURA | Buy | KURA ONCOLOGY INC | $5,500,000 | +45.0% | 400,000 | +60.0% | 0.21% | +39.5% |
| PRTA | New | PROTHENA CORP PLC | $4,749,000 | – | 300,000 | +100.0% | 0.18% | – |
| FATE | New | FATE THERAPEUTICS INCcall | $3,914,000 | – | 200,000 | +100.0% | 0.15% | – |
| KRTX | New | KARUNA THERAPEUTICS INC | $3,767,000 | – | 50,000 | +100.0% | 0.15% | – |
| NTLA | New | INTELLIA THERAPEUTICS INC | $2,930,000 | – | 199,700 | +100.0% | 0.11% | – |
| CRIS | New | CURIS INC | $2,550,000 | – | 1,500,000 | +100.0% | 0.10% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.